Dr. Overmoyer launched the Inflammatory Breast Cancer (IBC) Program at DF/BWCC in 2009, where she continues to serve as the principal investigator of many IBC research programs and clinical trials. She began her oncology career in 1989 at the University of Pennsylvania, where she trained in breast cancer and also participated in a major study in inflammatory breast cancer. She went on to develop the breast cancer program at the Cleveland Clinic and later developed two National Cancer Institute-sponsored studies on angiogenesis inhibitors and inflammatory breast cancer.
Dr. Beth Ann Overmoyer, MD
0
The iMedixStars rating goes beyond a simple average of reviews. It’s calculated based on various factors, including the quantity, recency, and reliability of the reviews. Read More
Overwiew
Doctor Organizations
- Brigham & Womens Hospital
Doctor Education
Medical School
1986
Case Western Reserve University School Of Medicine
Work Place
Dana Farber Cancer Institute
450 Brookline Ave
Boston
MA
02215
USA
+16176323000
Specialties
Procedures performed
- Chemotherapy
- Venipuncture
- Chemotherapy
Conditions
- Iron Deficiency Anemia
- Reviews
- Q&A
0 total
- 5 0 %
- 4 0 %
- 3 0 %
- 2 0 %
- 1 0 %
There are no questions!
Leave a comment